Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors
Paloma Cejas(Dana-Farber Cancer Institute), Ramesh A. Shivdasani(Dana-Farber Cancer Institute), Alba Font‐Tello(Dana-Farber Cancer Institute), Matthew H. Kulke(Brigham and Women's Hospital), Gerlof D. Valk(University Medical Center Utrecht), Tomer Adar(Harvard University), Mindy K. Graham(Johns Hopkins University), Koen M.A. Dreijerink(University Medical Center Utrecht), Holly Whitton(Broad Institute), Lodewijk A.A. Brosens(Utrecht University), Yotam Drier(Hebrew University of Jerusalem), Elizabeth Gaskell(Broad Institute), Vikram Deshpande(Beth Israel Deaconess Medical Center), Annacarolina da Silva(Cornell University), Ewa Sicińska(Harvard University), Christopher M. Heaphy(Boston University), Elfi B. Conemans(University Medical Center Utrecht), B Bernstein(Broad Institute), Cristina R. Ferrone(Cedars-Sinai Medical Center), Henry W. Long(Dana-Farber Cancer Institute), Folkert H.M. Morsink(University Medical Center Utrecht), Michaela Bowden(Brigham and Women's Hospital), Daniel C. Chung(Icahn School of Medicine at Mount Sinai), Carlos Fernández-del Castillo(Harvard University), Charles B. Epstein(Broad Institute), Menno R. Vriens(University Medical Center Utrecht), Noam Shoresh(Broad Institute)
Cited by 185
Related Papers
Model-based Analysis of ChIP-Seq (MACS)
|Genome biology|2008|20k
Comprehensive Mapping of Long-Range Interactions Reveals Folding Principles of the Human Genome
|Science|2009|9.6k